ArticleCureus2025
Disabilities Among Newly Reported Leprosy Cases in Visakhapatnam District, India: A Cross-Sectional Study of Prevalence and Associated Factors.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Burden of Disability, Poverty, and Unmet Needs Among Persons Affected by Hansen's Disease: Insights from Antulya Nagar, Pune- A Cross-Sectional Study.Journal of pharmacy & bioallied sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study evaluated disabilities among newly diagnosed leprosy cases in Visakhapatnam District, India, following the 2019 Leprosy Case Detection Campaign (LCDC). We aimed to quantify disability prevalence, classified by the World Health Organization (WHO) grades (0, 1, and 2), and identify associated sociodemographic and clinical factors. MATERIALS AND
methodsA cross-sectional analytical study included 68 out of 299 newly reported cases of leprosy selected via simple random sampling. Data were collected through clinical examinations, nerve assessments, and patient interviews after informed consent. Disability was graded per WHO criteria.
resultsParticipants (mean age: 36.7 ± 18.0 years) included 62% males and 81% aged 15-60 years; 39% were middle-class. Multibacillary leprosy predominated (63%), with 10% of child cases (<15 years), indicating active transmission. Disabilities were observed in 14% of the leprosy cases: 6% grade 1 and 9% grade 2 (exceeding India's 7.7% grade 2 average). Hands were most commonly affected (9%), with ulnar nerve involvement in 62% of the patients. Median healthcare-seeking delay was eight months, correlating with the proportion of grade 2 disabilities (G2D) observed. Stigma was a noted barrier, with patients reporting concealment of symptoms.
conclusionsDespite LCDC, high G2D rates persist, driven by delayed diagnosis and stigma. Recommendations include enhanced information education and communication, active case detection, and post-multidrug therapy follow-up. These findings support India's National Leprosy Eradication Program and global efforts to reduce leprosy-related disabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.